Pretreatment clinical prognostic factors for brain metastases from breast cancer treated with Gamma Knife radiosurgery

BACKGROUND: Brain metastases significantly affect morbidity and mortality rates for patients with metastatic breast cancer. Treatment for brain metastases lengthens survival, and options such as stereotactic radiosurgery (SRS) can increase survival to 12 months or longer. This study retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Roehrig, Andrew T., Ferrel, Ethan A., Benincosa, Devon A., MacKay, Alexander R., Ling, Benjamin C., Carlson, Jonathan D., Demakas, John J., Wagner, Aaron, Lamoreaux, Wayne T., Fairbanks, Robert K., Call, Jason A., Cooke, Barton S., Peressini, Ben, Lee, Christopher M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134111/
https://www.ncbi.nlm.nih.gov/pubmed/27990315
http://dx.doi.org/10.4103/2152-7806.194065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134111/
https://www.ncbi.nlm.nih.gov/pubmed/27990315
http://dx.doi.org/10.4103/2152-7806.194065

Ejemplares similares